As of Mar 16
| +0.09 / +5.26%|
The 1 analysts offering 12-month price forecasts for X T L Biopharmaceuticals Ltd have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 30.00. The median estimate represents a +1,566.66% increase from the last price of 1.80.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.